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Low dose cytokines reduce oxidative stress in
primary lesional fibroblasts obtained from
psoriatic patients
Psoriasis vulgaris is an inflammatory systemic disease with
unclear pathogenesis characterized by the appearance of scalyerythematous plaques on the skin. These plaques are the sites of
keratinocytes hyper-proliferation and misdifferentiation and
inflammatory infiltration by T cells skewed toward Th1/Th17 with
respect to Th2/TREG. Such disequilibrium between T cells
population features psoriasis as an autoimmune disease [1]. A
prominent attention is given to biologic drugs aimed to restore the
balance between T cells populations in psoriasis: the use of
antibodies against the overproduced cytokines or the use of
cytokines-antagonists represent two successful strategies that
have been shown to ameliorate Psoriasis Area Severity Indexin of psoriatic patients (LES) and from healthy donors (CTR).
) following 48 h incubation with 10 fg/ml of sequential-kinetic-activation (SKA) IL-4
t of LES with low dose cytokines significantly suppressed the emission of H2DCFDA
duction by flow cytometry where ROS production is expressed in percentage versus
each one performed in triplicate. *Significant difference (P  0.05) versus untreated
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treatments require the use of high dose biologics and are
frequently associated with adverse effects [2].
There are evidences that low doses of cytokines prepared by
sequential-kinetic-activation (SKA) are effective and reduce
adverse effects in psoriasis treatment with respect to standard
dose of recombinant cytokines. Thus, in a clinical trial involving 48
patients affected by psoriasis vulgaris, the oral administration of
SKA low-dose IL-4, IL-10 and IL-11 led to a significant reduction in
PASI index with no adverse events [3]. Previously, signs of
oxidative stress were found in the blood and skin of psoriatic
patients [4,5] and according to our data, anti-TNFa drug Infliximab
reduces oxidative stress in Peripheral Blood Mononuclear cells
(PBMC) from psoriatic patients [4]. Moreover, we recently showed
that the treatment with low dose SKA (femtograms per ml) IL-4, IL-
10, basic fibroblasts growth factor (bFGF) and b-endorphin
(b-End) decreases oxidative stress in perilesional keratinocytes
obtained from vitiligo skin [6].
In the present study the effect of low dose SKA cytokines in
fibroblasts from lesional skin of psoriatic patients was investigated.
We focused our attention on dermal fibroblasts because these cells
provide a crucial microenvironment for epidermal keratinocyte
function and, together with infiltrating polymorphonuclear
leukocytes were shown to extensively produce superoxide and
H2O2 impairing the redox balance in psoriatic derma andFig. 2. NADPH oxidase activity in intact primary fibroblasts obtained from the lesional
NADPH oxidase activity was measured by a luminometric assay following 48 h incubation
10), bFGF (LES + bFGF) or b-endorphin (LES + bEnd). Among all cytokines only bFGF led
histogram (C) represents the corresponding values in% normalized to CTR of area under 
higher in LES with respect to CTR fibroblasts. Reported values (means  SD) are represent
difference (P  0.05) versus untreated CTR, x Significant difference (P  0.05) versus unparticipating, at least partially, in abnormal keratinocytes growth
in psoriasis [7].
The following SKA cytokines (10 fg/ml) were used: (a) IL-10 and
IL-4 produced by TREGs and Th2, respectively; (b) b-endorphin,
neuropeptide that was shown to be increased in the serum of
psoriatic patients and produced directly in psoriatic plaques by
inflammatory cells [8]; and (c) bFGF that was shown to increase
cellular resistance to oxidative stress in vitro [9]. Lesional skin
punch biopsies were obtained from four patients affected by
plaque psoriasis and primary fibroblasts cell cultures were
established. Cells on passages 2–5 were used for experiments.
Cellular redox profile was determined by measuring intracellular
ROS production by flow cytometry analysis (fluorescent probe
H2DCFDA) and NADPH oxidase activity by luminometric assay [4].
In Fig. 1 a significantly higher total ROS production by lesional
fibroblasts with respect to control fibroblasts is shown 170  11%
versus 100  7%) respectively. In lesional fibroblasts NADPH
oxidase activity significantly raised (by 51.43  15%) compared to
control cells (Fig. 2).
In order to investigate the role of low dose SKA IL-4, IL-10, bFGF
and b-End on the above parameters, lesional fibroblasts were
incubated with each cytokine for 48 h and then total ROS production
and NADPH oxidase activity were measured. Interestingly, every
cytokine treatment significantly reduced intracellular ROS produc-
tion (Fig. 1): IL-4 by 29.3  3, IL-10 by 24.3  2, bFGF by 24.3  4 and skin (LES) of psoriatic patients and from healthy donors (CTR).
 with 10 fg/ml of sequential-kinetic-activation (SKA) IL-4 (LES + IL-4), IL-10 (LES + IL-
 to a significant down-regulation of NADPH oxidase activity in LES fibroblasts. The
the curve of NADPH oxidase activity. Extracellular ROS production was significantly
ative of five independent experiments, each one performed in triplicate. *Significant
treated LES.
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activity, only bFGF among selected cytokines was effective in
reducing this parameter in lesional cells to control level (Fig. 2).
Firstly, the results of our study demonstrate an increased ROS
production in lesional fibroblasts from psoriatic patients. More-
over, we show that also extracellular ROS production via NADPH
oxidase is significantly increased in lesional with respect to control
fibroblasts. Importantly, all experiments were performed in vitro,
in the absence of T cell infiltrates, so our data indicate the existence
of an intrinsic oxidative stress condition in psoriatic fibroblasts.
In particular, in psoriatic lesion, extracellular ROS overproduc-
tion by fibroblasts can exert a pro-inflammatory role in psoriatic
skin independently and in concomitance with infiltrating T cells.
Hence, redox balancing agents can represent an adjuvant therapy
for psoriasis. In the current work we studied the effect of low dose
SKA IL-4, IL-10, bFGF and b-End on the redox balance of lesional
fibroblasts. We found that all of selected cytokines decreased
significantly intracellular ROS production in lesional fibroblasts,
however, only bFGF was effective in reducing NADPH oxidase
activity. The inhibitory effect of bFGF on NADPH oxidase was
already shown in adipocytes via the mechanism of direct non
kinase-dependent coupling of bFGF receptor to G protein of NADPH
oxidase [10]. A similar mechanism could occur in psoriatic lesional
fibroblasts although further studies are needed. At the same time
IL-4, IL-10 and b-End act on intracellular ROS producing systems,
such as mitochondrial electron transport chain or xanthine
oxidase: other two main sources of ROS in the cell. Taken together,
our preliminary data show the effectiveness of low doses SKA IL-4,
IL-10, bFGF and b-End in modulation of oxidative stress in lesional
fibroblasts obtained from the skin of psoriatic patients. Although
further studies should be performed, the possible use of low dose
cytokines as a targeting treatment for psoriasis vulgaris can be
suggested.
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Association of interleukin (IL)18 and IL10 gene
polymorphisms with oral lichen planus risk; a
case-control study
Expression of both pro- and anti-inflammatory cytokines has
been reported in oral lichen planus (OLP) [1]. Interleukin-18 (IL18)
an interferon gamma (INFg) inducing agent is involved in OLP as it
is a potent pro-inflammatory cytokine besides its inhibitory effect
on the synthesis of IL10 [2]. IL-10 is an anti-inflammatory cytokinehaving a direct ability to down-regulate IL18 and INFg, which
makes it an important immunoregulator as well as a mediator of
inflammatory process [3].
Genetic factors producing disproportions in pro- and anti-
inflammatory cytokine production have been anticipated to
increase the susceptibility for OLP [1].
The above mentioned entangled cytokines network connections
drew our attention to investigate a possible association between
functional single nucleotide polymorphisms (SNPs) related to these
cytokines and OLP. The impactof these polymorphisms on tissue IL18
and IL10 expression was also determined.
This case-control study included 72 consecutive newly diag-
nosed OLP Egyptian patients and 75 apparently healthy Egyptian
volunteers as controls. All subjects were free from any systemic
